These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 32081616)
1. Targeting the cytochrome oxidases for drug development in mycobacteria. Lee BS; Sviriaeva E; Pethe K Prog Biophys Mol Biol; 2020 May; 152():45-54. PubMed ID: 32081616 [TBL] [Abstract][Full Text] [Related]
2. Exploiting the synthetic lethality between terminal respiratory oxidases to kill Kalia NP; Hasenoehrl EJ; Ab Rahman NB; Koh VH; Ang MLT; Sajorda DR; Hards K; Grüber G; Alonso S; Cook GM; Berney M; Pethe K Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7426-7431. PubMed ID: 28652330 [TBL] [Abstract][Full Text] [Related]
3. Dual inhibition of the terminal oxidases eradicates antibiotic-tolerant Mycobacterium tuberculosis. Lee BS; Hards K; Engelhart CA; Hasenoehrl EJ; Kalia NP; Mackenzie JS; Sviriaeva E; Chong SMS; Manimekalai MSS; Koh VH; Chan J; Xu J; Alonso S; Miller MJ; Steyn AJC; Grüber G; Schnappinger D; Berney M; Cook GM; Moraski GC; Pethe K EMBO Mol Med; 2021 Jan; 13(1):e13207. PubMed ID: 33283973 [TBL] [Abstract][Full Text] [Related]
4. Carbon metabolism modulates the efficacy of drugs targeting the cytochrome bc Kalia NP; Shi Lee B; Ab Rahman NB; Moraski GC; Miller MJ; Pethe K Sci Rep; 2019 Jun; 9(1):8608. PubMed ID: 31197236 [TBL] [Abstract][Full Text] [Related]
5. Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics? Bajeli S; Baid N; Kaur M; Pawar GP; Chaudhari VD; Kumar A Front Cell Infect Microbiol; 2020; 10():589318. PubMed ID: 33330134 [TBL] [Abstract][Full Text] [Related]
13. Nitric Oxide Does Not Inhibit but Is Metabolized by the Cytochrome Forte E; Giuffrè A; Huang LS; Berry EA; Borisov VB Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198276 [TBL] [Abstract][Full Text] [Related]
14. Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis. Foo CS; Lupien A; Kienle M; Vocat A; Benjak A; Sommer R; Lamprecht DA; Steyn AJC; Pethe K; Piton J; Altmann KH; Cole ST mBio; 2018 Oct; 9(5):. PubMed ID: 30301850 [TBL] [Abstract][Full Text] [Related]
15. M. tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environments. Kalia NP; Singh S; Hards K; Cheung CY; Sviriaeva E; Banaei-Esfahani A; Aebersold R; Berney M; Cook GM; Pethe K Cell Rep; 2023 May; 42(5):112444. PubMed ID: 37115669 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Mycobacterium tuberculosis Cytochrome Moosa A; Lamprecht DA; Arora K; Barry CE; Boshoff HIM; Ioerger TR; Steyn AJC; Mizrahi V; Warner DF Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760899 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome bd in Mycobacterium tuberculosis: A respiratory chain protein involved in the defense against antibacterials. Mascolo L; Bald D Prog Biophys Mol Biol; 2020 May; 152():55-63. PubMed ID: 31738981 [TBL] [Abstract][Full Text] [Related]
18. Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy. Zhou Y; Shao M; Wang W; Cheung CY; Wu Y; Yu H; Hu X; Cook GM; Gong H; Lu X Eur J Med Chem; 2023 Jan; 245(Pt 1):114896. PubMed ID: 36370551 [TBL] [Abstract][Full Text] [Related]
19. An amiloride derivative is active against the F Hards K; Cheung CY; Waller N; Adolph C; Keighley L; Tee ZS; Harold LK; Menorca A; Bujaroski RS; Buckley BJ; Tyndall JDA; McNeil MB; Rhee KY; Opel-Reading HK; Krause K; Preiss L; Langer JD; Meier T; Hasenoehrl EJ; Berney M; Kelso MJ; Cook GM Commun Biol; 2022 Feb; 5(1):166. PubMed ID: 35210534 [TBL] [Abstract][Full Text] [Related]
20. The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd. Lu P; Asseri AH; Kremer M; Maaskant J; Ummels R; Lill H; Bald D Sci Rep; 2018 Feb; 8(1):2625. PubMed ID: 29422632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]